Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy.

Fisicaro P, Rossi M, Vecchi A, Acerbi G, Barili V, Laccabue D, Montali I, Zecca A, Penna A, Missale G, Ferrari C, Boni C.

Int J Mol Sci. 2019 Oct 13;20(20). pii: E5080. doi: 10.3390/ijms20205080. Review.

2.

HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications.

Boni C, Barili V, Acerbi G, Rossi M, Vecchi A, Laccabue D, Penna A, Missale G, Ferrari C, Fisicaro P.

Int J Mol Sci. 2019 Jun 5;20(11). pii: E2754. doi: 10.3390/ijms20112754. Review.

3.

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.

Boni C, Janssen HLA, Rossi M, Yoon SK, Vecchi A, Barili V, Yoshida EM, Trinh H, Rodell TC, Laccabue D, Alfieri A, Brillo F, Fisicaro P, Acerbi G, Pedrazzi G, Andreone P, Cursaro C, Margotti M, Santoro R, Piazzolla V, Brunetto MR, Coco B, Cavallone D, Zhao Y, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Massetto B, Fung S, Ahn SH, Ma X, Mangia A, Ferrari C.

Gastroenterology. 2019 Jul;157(1):227-241.e7. doi: 10.1053/j.gastro.2019.03.044. Epub 2019 Mar 28.

PMID:
30930022
4.

Theoretical and experimental investigation of the focusing position in asymmetrical flow field-flow fractionation (AF4).

Wang JL, Alasonati E, Fisicaro P, Benedetti MF, Martin M.

J Chromatogr A. 2018 Aug 3;1561:67-75. doi: 10.1016/j.chroma.2018.04.056. Epub 2018 Apr 27.

PMID:
29843944
5.

Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming.

Fisicaro P, Boni C, Barili V, Laccabue D, Ferrari C.

Curr Opin Virol. 2018 Jun;30:1-8. doi: 10.1016/j.coviro.2018.01.003. Epub 2018 Feb 4. Review.

PMID:
29414066
6.

T cell regulation in HBV-related chronic liver disease.

Ferrari C, Boni C, Rossi M, Vecchi A, Barili V, Laccabue D, Fisicaro P, Missale G.

J Hepatol. 2017 May;66(5):1096-1098. doi: 10.1016/j.jhep.2016.10.002. Epub 2017 Feb 8. No abstract available.

PMID:
28189261
7.

Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.

Fisicaro P, Barili V, Montanini B, Acerbi G, Ferracin M, Guerrieri F, Salerno D, Boni C, Massari M, Cavallo MC, Grossi G, Giuberti T, Lampertico P, Missale G, Levrero M, Ottonello S, Ferrari C.

Nat Med. 2017 Mar;23(3):327-336. doi: 10.1038/nm.4275. Epub 2017 Feb 6.

PMID:
28165481
8.

Towards tributyltin quantification in natural water at the Environmental Quality Standard level required by the Water Framework Directive.

Alasonati E, Fettig I, Richter J, Philipp R, Milačič R, Sčančar J, Zuliani T, Tunç M, Bilsel M, Gören AC, Fisicaro P.

Talanta. 2016 Nov 1;160:499-511. doi: 10.1016/j.talanta.2016.07.056. Epub 2016 Jul 25.

PMID:
27591644
9.

Determination of tributyltin in whole water matrices under the European Water Framework Directive.

Richter J, Fettig I, Philipp R, Jakubowski N, Panne U, Fisicaro P, Alasonati E.

J Chromatogr A. 2016 Aug 12;1459:112-119. doi: 10.1016/j.chroma.2016.06.068. Epub 2016 Jun 22.

PMID:
27388657
10.

Accurate Quantification of Selenoprotein P (SEPP1) in Plasma Using Isotopically Enriched Seleno-peptides and Species-Specific Isotope Dilution with HPLC Coupled to ICP-MS/MS.

Deitrich CL, Cuello-Nuñez S, Kmiotek D, Torma FA, Del Castillo Busto ME, Fisicaro P, Goenaga-Infante H.

Anal Chem. 2016 Jun 21;88(12):6357-65. doi: 10.1021/acs.analchem.6b00715. Epub 2016 Jun 1.

PMID:
27108743
11.

Metrological challenges for measurements of key climatological observables: Oceanic salinity and pH, and atmospheric humidity. Part 1: Overview.

Feistel R, Wielgosz R, Bell SA, Camões MF, Cooper JR, Dexter P, Dickson AG, Fisicaro P, Harvey AH, Heinonen M, Hellmuth O, Kretzschmar HJ, Lovell-Smith JW, McDougall TJ, Pawlowicz R, Ridout P, Seitz S, Spitzer P, Stoica D, Wolf H.

Metrologia. 2016 Feb;53(1):R1-R11. Epub 2015 Dec 15.

12.

Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.

Zabaleta A, Riezu-Boj JI, Larrea E, Villanueva L, Lasarte JJ, Guruceaga E, Fisicaro P, Ezzikouri S, Missale G, Ferrari C, Benjelloun S, Prieto J, Sarobe P.

J Med Virol. 2016 May;88(5):843-51. doi: 10.1002/jmv.24399. Epub 2015 Oct 19.

PMID:
26447929
13.

Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.

Boni C, Lampertico P, Talamona L, Giuberti T, Invernizzi F, Barili V, Fisicaro P, Rossi M, Cavallo MC, Vecchi A, Pedrazzi G, Alfieri A, Colombo M, Missale G, Ferrari C.

Hepatology. 2015 Dec;62(6):1697-709. doi: 10.1002/hep.28155. Epub 2015 Oct 29.

PMID:
26361374
14.

Experimental design for TBT quantification by isotope dilution SPE-GC-ICP-MS under the European water framework directive.

Alasonati E, Fabbri B, Fettig I, Yardin C, Del Castillo Busto ME, Richter J, Philipp R, Fisicaro P.

Talanta. 2015 Mar;134:576-586. doi: 10.1016/j.talanta.2014.11.064. Epub 2014 Dec 6.

PMID:
25618710
15.

Certification of a reference material of metal content in atmospheric particles deposited on filters.

Oster C, Labarraque G, Fisicaro P.

Anal Bioanal Chem. 2015 Apr;407(11):3035-43. doi: 10.1007/s00216-014-8194-9. Epub 2014 Sep 27.

PMID:
25260410
16.

Method development for genomic Legionella pneumophila DNA quantification by inductively coupled plasma mass spectrometry.

Leclerc O, Fraisse PO, Labarraque G, Oster C, Pichaut JP, Baume M, Jarraud S, Fisicaro P, Vaslin-Reimann S.

Anal Biochem. 2013 Apr 15;435(2):153-8. doi: 10.1016/j.ab.2012.12.023. Epub 2013 Jan 16.

PMID:
23333226
17.

Metalloproteins--a new challenge for metrology.

Swart C, Fisicaro P, Goenaga-Infante H, Zakel S.

Metallomics. 2012 Nov;4(11):1137-40. doi: 10.1039/c2mt90049a. Epub 2012 Sep 19. No abstract available.

PMID:
22992628
18.

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

Fisicaro P, Valdatta C, Massari M, Loggi E, Ravanetti L, Urbani S, Giuberti T, Cavalli A, Vandelli C, Andreone P, Missale G, Ferrari C.

Gastroenterology. 2012 Dec;143(6):1576-1585.e4. doi: 10.1053/j.gastro.2012.08.041. Epub 2012 Aug 25.

PMID:
22929808
19.

Uptake of selenite by Saccharomyces cerevisiae involves the high and low affinity orthophosphate transporters.

Lazard M, Blanquet S, Fisicaro P, Labarraque G, Plateau P.

J Biol Chem. 2010 Oct 15;285(42):32029-37. doi: 10.1074/jbc.M110.139865. Epub 2010 Aug 5.

20.

Activation of natural killer cells during acute infection with hepatitis C virus.

Amadei B, Urbani S, Cazaly A, Fisicaro P, Zerbini A, Ahmed P, Missale G, Ferrari C, Khakoo SI.

Gastroenterology. 2010 Apr;138(4):1536-45. doi: 10.1053/j.gastro.2010.01.006. Epub 2010 Jan 18.

21.

A systematic approach to the accurate quantification of selenium in serum selenoalbumin by HPLC-ICP-MS.

Jitaru P, Goenaga-Infante H, Vaslin-Reimann S, Fisicaro P.

Anal Chim Acta. 2010 Jan 11;657(2):100-7. doi: 10.1016/j.aca.2009.10.037.

PMID:
20005320
22.

Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.

Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, Cavallo MC, Silini EM, Andreone P, Missale G, Ferrari C.

Gastroenterology. 2010 Feb;138(2):682-93, 693.e1-4. doi: 10.1053/j.gastro.2009.09.052. Epub 2009 Sep 30.

PMID:
19800335
23.

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G, Ferrari C.

Gut. 2009 Jul;58(7):974-82. doi: 10.1136/gut.2008.163600. Epub 2009 Feb 6.

PMID:
19201769
24.

Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.

Tan AT, Loggi E, Boni C, Chia A, Gehring AJ, Sastry KS, Goh V, Fisicaro P, Andreone P, Brander C, Lim SG, Ferrari C, Bihl F, Bertoletti A.

J Virol. 2008 Nov;82(22):10986-97. doi: 10.1128/JVI.01124-08. Epub 2008 Sep 17.

25.

The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G.

Gastroenterology. 2008 May;134(5):1470-81. doi: 10.1053/j.gastro.2008.02.017. Epub 2008 Feb 14.

PMID:
18355815
26.

Assessment of the uncertainty budget for the amperometric measurement of dissolved oxygen.

Fisicaro P, Adriaens A, Ferrara E, Prenesti E.

Anal Chim Acta. 2007 Jul 30;597(1):75-81. Epub 2007 Jun 20.

PMID:
17658315
27.

Development of a reference solution for the pH of seawater.

Prenesti E, Ferrara E, Berto S, Fisicaro P, Daniele PG.

Anal Bioanal Chem. 2007 Aug;388(8):1877-83. Epub 2007 Jul 7.

PMID:
17619179
28.

Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.

Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, Bertoletti A, Ferrari C.

J Virol. 2007 Apr;81(8):4215-25. Epub 2007 Feb 7.

29.

Monitoring the traceability of the pH of a primary tetraborate buffer: comparison of results from primary and secondary apparatus.

Prenesti E, Fisicaro P, Berto S, Ferrara E, Daniele PG.

Anal Bioanal Chem. 2007 Apr;387(7):2595-600. Epub 2007 Jan 24.

PMID:
17245528
30.

Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.

Urbani S, Amadei B, Fisicaro P, Tola D, Orlandini A, Sacchelli L, Mori C, Missale G, Ferrari C.

Hepatology. 2006 Jul;44(1):126-39.

PMID:
16799989
31.

The influence of T cell cross-reactivity on HCV-peptide specific human T cell response.

Kennedy PT, Urbani S, Moses RA, Amadei B, Fisicaro P, Lloyd J, Maini MK, Dusheiko G, Ferrari C, Bertoletti A.

Hepatology. 2006 Mar;43(3):602-11.

PMID:
16496333
32.

The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection.

Urbani S, Amadei B, Cariani E, Fisicaro P, Orlandini A, Missale G, Ferrari C.

J Immunol. 2005 Dec 1;175(11):7519-29.

34.

Heterologous T cell immunity in severe hepatitis C virus infection.

Urbani S, Amadei B, Fisicaro P, Pilli M, Missale G, Bertoletti A, Ferrari C.

J Exp Med. 2005 Mar 7;201(5):675-80.

35.

Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.

Urbani S, Boni C, Amadei B, Fisicaro P, Cerioni S, Valli MA, Missale G, Ferrari C.

Hepatology. 2005 Apr;41(4):826-31.

PMID:
15726541
36.

Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection.

Boni C, Amadei B, Urbani S, Fisicaro P, Zerbini A, Mori C, Missale G, Bertoni R, Azzurri A, Del Prete G, Ferrari C.

Hepatology. 2004 Aug;40(2):289-99.

PMID:
15368433
37.
38.

Oxidation States of Copper Ions in ZSM-5 Zeolites. A Multitechnique Investigation.

Turnes Palomino G, Fisicaro P, Bordiga S, Zecchina A, Giamello E, Lamberti C.

J Phys Chem B. 2000 May 4;104(17):4064-4073. doi: 10.1021/jp993893u.

PMID:
28960984
39.

A transphyletic anti-infectious control strategy based on the killer phenomenon.

Conti S, Magliani W, Gerloni M, Salati A, Dieci E, Arseni S, Fisicaro P, Polonelli L.

FEMS Immunol Med Microbiol. 1998 Sep;22(1-2):151-61. Review.

40.

Killer antibodies in fungal infections.

Conti S, Magliani W, Fisicaro P, Dieci E, Arseni S, Salati A, Polonelli L.

Res Immunol. 1998 May-Jun;149(4-5):334-43; discussion 523. Review. No abstract available.

PMID:
9720951
41.

Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics.

Salonen EM, Parren PW, Graus YF, Lundkvist A, Fisicaro P, Vapalahti O, Kallio-Kokko H, Vaheri A, Burton DR.

J Gen Virol. 1998 Apr;79 ( Pt 4):659-65.

PMID:
9568958
42.

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

Parren PW, Gauduin MC, Koup RA, Poignard P, Sattentau QJ, Fisicaro P, Burton DR.

Immunol Lett. 1997 Jul;58(2):125-32. Review.

PMID:
9271324
43.

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.

Parren PW, Gauduin MC, Koup RA, Poignard P, Fisicaro P, Burton DR, Sattentau QJ.

Immunol Lett. 1997 Jun 1;57(1-3):105-12. Review. Corrected and republished in: Immunol Lett. 1997 Jul;58(2):125-32.

PMID:
9232434
44.

Reactivity of Candida albicans germ tubes with salivary secretory IgA.

Pontón J, Bikandi J, Moragues MD, Arilla MC, Elósegui R, Quindós G, Fisicaro P, Conti S, Polonelli L.

J Dent Res. 1996 Dec;75(12):1979-85.

PMID:
9033453
45.

In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope.

Parren PW, Fisicaro P, Labrijn AF, Binley JM, Yang WP, Ditzel HJ, Barbas CF 3rd, Burton DR.

J Virol. 1996 Dec;70(12):9046-50.

46.

Killer factor interference in mixed opportunistic yeast cultures.

Conti S, Cantelli C, Gerloni M, Fisicaro P, Magliani W, Bertolotti D, Mozzoni P, Sullivan D, Coleman D, Polonelli L.

Mycopathologia. 1996;135(1):1-8.

PMID:
9008877
47.

Candida albicans stress mannoproteins expression in superficial and systemic candidiasis. Stress mannoproteins in Candida albicans.

Pontón J, Hernando FL, Moragues MD, Barea PL, Gerloni M, Conti S, Fisicaro P, Cantelli C, Polonelli L.

Mycopathologia. 1996;133(2):89-94.

PMID:
8751828
48.

Use of yeast killer system to identify species of the Nocardia asteroides complex.

Provost F, Polonelli L, Conti S, Fisicaro P, Gerloni M, Boiron P.

J Clin Microbiol. 1995 Jan;33(1):8-10.

49.

Heat-shock mannoproteins as targets of secretory IgA in Candida albicans.

Polonelli L, Gerloni M, Conti S, Fisicaro P, Cantelli C, Portincasa P, Almondo F, Barea PL, Hernando FL, Ponton J.

J Infect Dis. 1994 Jun;169(6):1401-5.

PMID:
7515089

Supplemental Content

Loading ...
Support Center